PHQ-2

I'm not gonna go through each one specifically, but it's important that you recognize there's a lot of tools out there, and based on your setting, which one makes the most sense for you to bring in.

The AUDIT and the AUDIT C3 is kind of like the PHQ, Q9 and the PHQ-2.

[laughs] So different variations in terms of how much depth you go into.

The CAGE is kind of like a very old school one.

A screening tool called SMARTE was developed to bridge this gap.

And it incorporates the Mini-Cog for cognition, the PHQ-2 for depression, and frailty assessments.

What did the data from these holistic screens reveal?

The SMARTE tool showed that baseline cognitive deficits independently predict postoperative delirium and thirty-day mortality.

So that is definitely one that oncology nurses should be very, very familiar with, should advocate for patients to have access to that at each encounter at the cancer center or periodically according to what would be the best fit for that cancer center.

Oncology nurses should also be very familiar with the PHQ-2 and the PHQ-9.

Those scales assess patients feeling sad, low, depressed, having difficulty in joint interest, and then the PHQ-9 is a full depression assessment.

There's also the end of the PHQ-9 does assess self-harm and suicide risk.